1Hansel T T, Barnes P J. Tiotropium bromide:a novel once-daily anticholinergic bronchodilator for the treatment of COPD [ J ]. Drugs Today(Barc). 2002,38(9) :585 -600
2Reinoud G, I Sophie T Bos, Johan Zaagsma,et al. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling[J]. Am J Respir Crit Care Med. 2005,171 (10) : 1096-1102
3Calverley PM, Lee A, Towse L, et al. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease[J]. Thorax. 2003,58 (10) : 855 -860
4Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease[J]. Eur Respir J. 2002,19 (2) : 217 -224
5Hasani A, Toms N, Agnew JE, et al. The effect of inhaled tiotropium bromide on singlelung mucociliary clearance in patients with COPD[J]. Chest. 2004,125 (5) :1726 - 1734
6Casaburi R, Briggs D, Donohue JF,et al. The Spirometric efficacy of once-daily dosing with tiotropium in stable COPD[ J ]. Chest. 2000,118 : 1294 - 1302
7Michael R Littner, Jonathan S Ilowite, Donald P Tashkin, et al.Long-Acting bronchodilation with once- daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000,161:1136 - 1142
8Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses[J]. Chest. 2003,123 (5) : 1441 - 1449
9Donohue JF, Van Noord A, Bateman ED, et al. A 6-month, placebo-controlledstudy comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol [ J ]. Chest.2002,122 ( 1 ) : 47-55
10Brusasco V, Hodder R, Miravitlles M, et al. Health outcomes following treatmentfor six months with once daily tiotropium compared with twice daily salmeterolin patients with COPD[J]. Thorax. 2003,58 (5):399-404
5[13]Sheng Lin,Masayoshi Kajimura,Ken Takeuchi,et al.Expression of Muscarinic Receptor Subtypes in Rat Gastric Smooth Muscle[J].Digestive Diseases and Sciences,1997,42(5):907-914.
6[14]Koji Takeuchi,Youichi Nobuhara.Inhibition of Gastric Motor Activity by 16,16-Dimethyl Prostaglandin E2[J].Digestive Diseases and Sciences,1985,30(12):1181-1188.
7[18]Watanabe H,Kawawchi A.Noctural enuresis:social aspects and treatment perspectives in Japan[J].Scan Urol Nephrol,1994,163(suppl):29.
8[19]M.Cendron,G Klauber.Combination Therapy In the Treatment of Persistent Nocturnal Enuresis[J].British Journal of Urology,1998,81(suppl)3:26-28.
9[21]Takahiro Kobayashi,Takahisa Ikeue,Tsuyoshi Ito,etal.Short-Term Exposure to Diesel Exhaust Induces Nasal Mucosal Hyperresponsiveness to Histamine in Guinea pigs[J].Fundamental and Applied Toxicology,1997,38:166-172.
10[22]Takahiro kobayashi,Tsuyosh Ito.Diesel Exhaust Particulates Induces Nasal Mucosal Hyperresponsivness to Znhaled Histamine Aerosol[J].Funda-mental and Applied Toxicology,1995,27:195-202.
3Cazzola M, Matera M G. Long-acting bronchodilators are the firstchoice option for the treatment of stable COPD [J]. Chest, 2004, 125(1):9-11.
4Lee J S, Rosengart M R, Kondragunta V, et al. Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study [J]. Respir Res, 2007,8 : 64.
